Cargando…

Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance

Histone modification is associated with resistance to anti-cancer drugs. Epigenetic modifications of histones can regulate resistance to anti-cancer drugs. It has been reported that histone deacetylase 3 (HDAC3) regulates responses to anti-cancer drugs, angiogenic potential, and tumorigenic potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Yoojung, Kim, Youngmi, Jung, Hyun Suk, Jeoung, Dooil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337380/ https://www.ncbi.nlm.nih.gov/pubmed/30583572 http://dx.doi.org/10.3390/ijms20010051

Ejemplares similares

The Hyaluronic Acid–HDAC3–miRNA Network in Allergic Inflammation
por: Kim, Youngmi, et al.
Publicado: (2015)

FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions
por: Kim, Misun, et al.
Publicado: (2019)

Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
por: Kwon, Yoojung, et al.
Publicado: (2019)

EGR3-HDAC6-IL-27 Axis Mediates Allergic Inflammation and Is Necessary for Tumorigenic Potential of Cancer Cells Enhanced by Allergic Inflammation-Promoted Cellular Interactions
por: Kwon, Yoojung, et al.
Publicado: (2021)

miR-30a Regulates the Expression of CAGE and p53 and Regulates the Response to Anti-Cancer Drugs
por: Park, Deokbum, et al.
Publicado: (2016)

Homoharringtonine Inhibits Allergic Inflammations by Regulating NF-κB-miR-183-5p-BTG1 Axis
por: Kim, Misun, et al.
Publicado: (2020)

HDAC6 and CXCL13 Mediate Atopic Dermatitis by Regulating Cellular Interactions and Expression Levels of miR-9 and SIRT1
por: Kwon, Yoojung, et al.
Publicado: (2021)

miR-335 Targets SIAH2 and Confers Sensitivity to Anti-Cancer Drugs by Increasing the Expression of HDAC3
por: Kim, Youngmi, et al.
Publicado: (2015)

Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages
por: Kwon, Yoojung, et al.
Publicado: (2020)

CAGE Binds to Beclin1, Regulates Autophagic Flux and CAGE-Derived Peptide Confers Sensitivity to Anti-cancer Drugs in Non-small Cell Lung Cancer Cells
por: Yeon, Minjeong, et al.
Publicado: (2018)

Histone Deacetylase-3/CAGE Axis Targets EGFR Signaling and Regulates the Response to Anti-Cancer Drugs
por: Kim, Hyuna, et al.
Publicado: (2016)

MiR-154-5p-MCP1 Axis Regulates Allergic Inflammation by Mediating Cellular Interactions
por: Kim, Misun, et al.
Publicado: (2021)

The CAGE–MiR-181b-5p–S1PR1 Axis Regulates Anticancer Drug Resistance and Autophagy in Gastric Cancer Cells
por: Yeon, Minjeong, et al.
Publicado: (2021)

Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs
por: Kim, Youngmi, et al.
Publicado: (2015)

HDAC2 as a target for developing anti-cancer drugs
por: Jo, Hyein, et al.
Publicado: (2023)

Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
por: Jo, Hyein, et al.
Publicado: (2022)

Human Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Atopic Dermatitis by Regulating the Expression of MIP-2, miR-122a-SOCS1 Axis, and Th1/Th2 Responses
por: Kim, Misun, et al.
Publicado: (2018)

CAGE-miR-140-5p-Wnt1 Axis Regulates Autophagic Flux, Tumorigenic Potential of Mouse Colon Cancer Cells and Cellular Interactions Mediated by Exosomes
por: Yeon, Minjeong, et al.
Publicado: (2019)

miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2
por: Kim, Youngmi, et al.
Publicado: (2016)

HDAC3 acts as a negative regulator of angiogenesis
por: Park, Deokbum, et al.
Publicado: (2014)

Nuclear localization signal domain of HDAC3 is necessary and sufficient for the expression regulation of MDR1
por: Park, Hyunmi, et al.
Publicado: (2014)

MiR-135-5p-p62 Axis Regulates Autophagic Flux, Tumorigenic Potential, and Cellular Interactions Mediated by Extracellular Vesicles During Allergic Inflammation
por: Kim, Misun, et al.
Publicado: (2019)

Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma
por: Yeon, Minjeong, et al.
Publicado: (2020)

The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1
por: Kim, Youngmi, et al.
Publicado: (2017)

Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
por: Jo, Hyein, et al.
Publicado: (2023)

DDX53 Promotes Cancer Stem Cell-Like Properties and Autophagy
por: Kim, Hyuna, et al.
Publicado: (2017)

DDX53 Regulates Cancer Stem Cell-Like Properties by Binding to SOX-2
por: Kim, Youngmi, et al.
Publicado: (2017)

Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics
por: Jo, Hyein, et al.
Publicado: (2022)

Cancer/testis antigen CAGE mediates osimertinib resistance in non-small cell lung cancer cells and predicts poor prognosis in patients with pulmonary adenocarcinoma
por: Yeon, Minjeong, et al.
Publicado: (2023)

HDAC2‐dependent miRNA signature in acute myeloid leukemia
por: Conte, Mariarosaria, et al.
Publicado: (2019)

Polysome shift assay for direct measurement of miRNA inhibition by anti-miRNA drugs
por: Androsavich, John R., et al.
Publicado: (2016)

HDAC-Linked “Proliferative” miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors
por: Klieser, Eckhard, et al.
Publicado: (2018)

Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer’s disease
por: Li, Zhengyu, et al.
Publicado: (2020)

Botulinum toxin A-induced muscle paralysis stimulates Hdac4 and differential miRNA expression
por: Worton, Leah E., et al.
Publicado: (2018)

MiRNAs and miRNA Polymorphisms Modify Drug Response
por: Li, Mu-Peng, et al.
Publicado: (2016)

TLNPMD: Prediction of miRNA-Disease Associations Based on miRNA-Drug-Disease Three-Layer Heterogeneous Network
por: Yang, Yi, et al.
Publicado: (2022)

Discovering the ‘Dark matters’ in expression data of miRNA based on the miRNA-mRNA and miRNA-lncRNA networks
por: Pian, Cong, et al.
Publicado: (2018)

Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
por: Shim, Kyeonghee, et al.
Publicado: (2023)

Analyzing miRNA co-expression networks to explore TF-miRNA regulation
por: Bandyopadhyay, Sanghamitra, et al.
Publicado: (2009)

MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features
por: Xu, Juan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_r3omt7dcdc67ukrb8hau5t5j6b